Reactive airway disease (RAD) is a condition that affects many children, and can be a source of confusion and distress for parents. RAD is a type of asthma, and is characterized by recurrent episodes of wheezing, coughing, and difficulty breathing. This guide will provide parents with the information they need to understand and manage their child’s RAD.
Reactive airway disease (RAD) is a type of asthma, and is characterized by recurrent episodes of wheezing, coughing, and difficulty breathing. RAD is caused by inflammation of the airways, and is often triggered by exposure to allergens or irritants. Common triggers include smoke, dust, animal dander, and pollen. RAD can also be triggered by physical activity, cold weather, and viral infections.
The most common symptoms of RAD are wheezing, coughing, and difficulty breathing. Wheezing is a whistling sound that occurs when a person breathes, and is caused by narrowed airways. Coughing is a reflex that helps clear the airways of mucus and other irritants. Difficulty breathing is a feeling of tightness in the chest or shortness of breath. Other symptoms of RAD include fatigue, chest pain, and difficulty sleeping.
RAD is diagnosed by a doctor based on the patient’s symptoms, medical history, and physical examination. The doctor may also order tests such as chest X-rays, lung function tests, and blood tests to confirm the diagnosis.
The goal of treatment for RAD is to reduce symptoms and prevent future episodes. Treatment usually involves avoiding triggers, taking medications, and using breathing techniques.
The first step in managing RAD is to identify and avoid triggers. Common triggers include smoke, dust, animal dander, and pollen. It is important to avoid exposure to these triggers as much as possible.
Medications are used to reduce inflammation and open the airways. Common medications include inhalers, nebulizers, and oral medications. Inhalers are devices that deliver medication directly to the lungs. Nebulizers are machines that turn liquid medication into a mist that is inhaled. Oral medications are taken by mouth.
Breathing techniques can help to reduce symptoms and prevent future episodes. Common breathing techniques include pursed-lip breathing, diaphragmatic breathing, and abdominal breathing. Pursed-lip breathing involves breathing in slowly through the nose and out slowly through the mouth. Diaphragmatic breathing involves taking slow, deep breaths and focusing on the diaphragm. Abdominal breathing involves taking slow, deep breaths and focusing on the abdomen.
Reactive airway disease (RAD) is a type of asthma that affects many children. Symptoms include wheezing, coughing, and difficulty breathing. Treatment involves avoiding triggers, taking medications, and using breathing techniques. With the right management, RAD can be effectively managed and symptoms can be reduced. This guide has provided parents with the information they need to understand and manage their child’s RAD.
1.
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma
2.
The Early Progression of Prostate Cancer Is Not Stopped by Metformin.
3.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
4.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
5.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
1.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Understanding Iron Saturation Levels in Your Blood
4.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
5.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation